Business & Regulation

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?

Sitting Down With… Sir Alasdair Breckenridge; Chairman of the Advisory Board, the Centre of Regulatory Excellence of the Government of Singapore...

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

Here we discuss the problems of handling living, breathing cells in transit...

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

Single-source chromatography resin leads to requirements for supply security.

What does the controversial genome editing work of Jiankui He mean for biomedical research?